Drug Type Chemical drugs |
Synonyms BGN 112, BGN112 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | South Korea | 01 Nov 2024 | |
Amyotrophic Lateral Sclerosis | Preclinical | South Korea | 01 Nov 2024 | |
Colitis | Preclinical | South Korea | 01 Nov 2024 | |
Glomerulonephritis | Preclinical | South Korea | 01 Nov 2024 | |
Niemann-Pick Disease, Type C | Preclinical | South Korea | 01 Nov 2024 | |
Parkinsonian Disorders | Preclinical | South Korea | 01 Nov 2024 |